Phenotype information is crucial for the interpretation of genomic variants. So far it has only 88 been accessible for bioinformatics workflows after encoding into clinical terms by expert 89
102
symptoms, and treatment, making diagnosis an important yet challenging healthcare issue. Due to 103 extensive clinical variability this is true even for well characterized syndromes. 1, 3 104 Worldwide, more than half a million children born per year have a rare genetic disorder that is suitable 105 for a diagnostic workup by exome sequencing, which has an unprecedented diagnostic yield for many 106 indications such as developmental delay. [4] [5] [6] [7] [8] [9] The main remaining concern for the integration of exome 107 sequencing into clinical routine is to increase the efficiency of genetic variant interpretation. Making 108 phenotypic information -the observable, clinical presentation -computer-readable is key in solving 109 this problem, and in providing clinicians with a much-needed tool for diagnosing genetic syndromes. 10 110 To date, the most advanced exome prioritization algorithms combine deleteriousness scores for 111 mutations with semantic similarity searches of the clinical description of a patient. [11] [12] [13] [14] [15] The human 112 phenotype ontology (HPO) with its extensive vocabulary has become the lingua franca for this 113 purpose. 16 However, semantic similarity searches presuppose that facial features can be named. A 114 facial gestalt that is simply described in the literature as typical or characteristic of a certain disease is 115 of little help for these approaches.
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Beyond language, capturing indicative patterns by deep-learning approaches has recently gained 117 attention in assessing facial dysmorphism. 17-21 Artificial neural networks are now able to quantify the 118 similarities of patient photos to hundreds of disease entities and achieve accuracies that match or even 119 surpass the level of dysmorphologists in certain tasks. [22] [23] [24] [25] For this reason tools such as Face2Gene are 120 now used in addition to human expertise to guide the molecular testing and to interpret sequence 121 variants. Here we investigate systematically whether facial image analysis can improve the evaluation 122 of exome data and qualifies as a next-generation phenotyping technology for next-generation 123 sequencing. 26
124

Results
125
We first present an overview about the approach to prioritize exome data by image analysis (PEDIA); 126 a detailed description is provided in the Methods.
128
PEDIA classifier. For the assessment of genetic variants, different sources of evidence have to be 129 considered, from a populational, molecular, and phenotypic level. PEDIA is a Bayesian heuristic, that 130 can be used to update the probability that a mutation in a gene is disease-causing, given the 131 phenotypic information contained in a frontal photograph.
132
To build this classifier, we first measured the similarities of the facial gestalt to 216 specific diseases in 133 679 individuals with the convolutional neural network DeepGestalt. 21 By this means, we were able to 134 acquire scores for disorders with a single genetic etiology that quantify the PP4 criteria of the ACMG 135 guidelines which is used for variant interpretation. 27, 28 136 In addition to DeepGestalt, we computed further prediction scores that are widely used on clinical 137 features (Phenomizer, Boqa, Feature) and genetic variants (CADD) for all individuals of the PEDIA 138 cohort ( Supplemental Table 1 ). 29, 30, 31 With this data set we trained and tested a support vector 139 machine that can be used to prioritize the genetic variants in a VCF files from exome sequencing.
140
Gene prioritization.
141
The term next-generation sequencing (NGS) implies the interrogation of all genes in a single assay.
142
Similarly, the term next-generation phenotyping (NGP) refers to technology enabling similarity 143 searches on a large set of disorders based on clinical patient records and medical imaging data. In order 144 to increase the efficiency in diagnostics, we combined both approaches and benchmarked gene 145 prioritization.
146
Similar to the performance readout in Gurovich et al., the identification of the disease-gene in exome 147 data also represents a multiclass classification problem and the number of sequence variants in the 148 coding part of the genome illustrates the complexity of the diagnostic assessment. In reference guided-149 resequencing, about 20,000-30,000 single nucleotide variants and small indels have to be considered.
150
Although the majority of these variants can be removed as benign polymorphisms, rare and potentially 151 disease-causing mutations in more than 100 genes remain in a typical case with a suspected 152 monogenic disorder. When only a deleteriousness score such as CADD is used to rank these mutations, 
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The efficiency of a prioritization algorithm can also be measured by the area under the curve (AUC) of 173 the disease-causing mutation versus its ranked position. The higher the AUC, the higher the diagnostic 174 yield in a fixed amount of time that is spend on the analysis of sequence variants (Figure 3 ). Combining 175 similarity scores from image analysis, phenotypic features and molecular deleteriousness achieves the 176 best AUC on the PEDIA cohort and is therefore suited to speed up diagnostics.
177
The contribution from the different sources of evidence to the PEDIA score is also reflected by the 178 relative weight of the deleteriousness of the mutation (0.44), all feature-based scores combined (0.25) 179 and the results from image analysis by DeepGestalt (0.31) that can be derived from a linear SVM model.
180
We therefore also conclude that the information contained in a frontal photograph of patient goes 
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The only way to overcome the biases of semantic similarity metrics as well as AI-driven image analysis 222 that are due to limited cohort sizes, is sharing of the phenotypic data sets.
223
In conclusion, the PEDIA study documents that exome variant interpretation benefits from computer-224 assisted image analysis of facial photographs, particularly if dysmorphism has been stated in the 225 clinical notes. By including similarity scores from DeepGestalt, we improved the top-10-accuracy rate 226 considerably. AI-driven pattern recognition of frontal facial patient photographs is an example of next-227 generation phenotyping technology with proven clinical value in the interpretation of next-generation 228 sequencing data.
229
As deep-learning advances in the assessment of other medical imaging data, it will be interesting to 230 study how these classifiers affect variant interpretation separately and in aggregate. 35, 36 
